nodes	percent_of_prediction	percent_of_DWPC	metapath
Cilazapril—ABCB1—lung cancer	0.321	1	CbGaD
Cilazapril—ABCB1—Topotecan—lung cancer	0.0515	0.136	CbGbCtD
Cilazapril—ABCB1—Gefitinib—lung cancer	0.0471	0.124	CbGbCtD
Cilazapril—ABCB1—Vinorelbine—lung cancer	0.0363	0.0958	CbGbCtD
Cilazapril—ABCB1—Crizotinib—lung cancer	0.0289	0.0762	CbGbCtD
Cilazapril—ABCB1—Gemcitabine—lung cancer	0.0282	0.0745	CbGbCtD
Cilazapril—ABCB1—Erlotinib—lung cancer	0.0278	0.0735	CbGbCtD
Cilazapril—ABCB1—Paclitaxel—lung cancer	0.0255	0.0673	CbGbCtD
Cilazapril—ABCB1—Irinotecan—lung cancer	0.0251	0.0664	CbGbCtD
Cilazapril—ABCB1—Vinblastine—lung cancer	0.0224	0.059	CbGbCtD
Cilazapril—ABCB1—Cisplatin—lung cancer	0.0205	0.0541	CbGbCtD
Cilazapril—ABCB1—Etoposide—lung cancer	0.0201	0.0532	CbGbCtD
Cilazapril—ABCB1—Docetaxel—lung cancer	0.0184	0.0486	CbGbCtD
Cilazapril—ABCB1—Doxorubicin—lung cancer	0.0137	0.0363	CbGbCtD
Cilazapril—ABCB1—Methotrexate—lung cancer	0.0133	0.0351	CbGbCtD
Cilazapril—ACE—pulmonary artery—lung cancer	0.0114	0.286	CbGeAlD
Cilazapril—ACE—umbilical vein—lung cancer	0.00756	0.189	CbGeAlD
Cilazapril—SLC15A2—mammary gland—lung cancer	0.00252	0.0629	CbGeAlD
Cilazapril—SLC15A1—epithelium—lung cancer	0.00224	0.0561	CbGeAlD
Cilazapril—ACE—respiratory system—lung cancer	0.00192	0.0481	CbGeAlD
Cilazapril—SLC15A2—respiratory system—lung cancer	0.00168	0.0419	CbGeAlD
Cilazapril—ACE—epithelium—lung cancer	0.00161	0.0402	CbGeAlD
Cilazapril—SLC15A2—bronchus—lung cancer	0.00138	0.0345	CbGeAlD
Cilazapril—ACE—cardiac atrium—lung cancer	0.00134	0.0334	CbGeAlD
Cilazapril—SLC15A2—trachea—lung cancer	0.00124	0.031	CbGeAlD
Cilazapril—ACE—bone marrow—lung cancer	0.00113	0.0282	CbGeAlD
Cilazapril—ACE—lung—lung cancer	0.00102	0.0255	CbGeAlD
Cilazapril—SLC15A2—lung—lung cancer	0.000891	0.0223	CbGeAlD
Cilazapril—ACE—lymph node—lung cancer	0.000699	0.0175	CbGeAlD
Cilazapril—ABCB1—respiratory system—lung cancer	0.000677	0.0169	CbGeAlD
Cilazapril—SLC15A2—lymph node—lung cancer	0.000609	0.0152	CbGeAlD
Cilazapril—ABCB1—epithelium—lung cancer	0.000566	0.0141	CbGeAlD
Cilazapril—ABCB1—trachea—lung cancer	0.000501	0.0125	CbGeAlD
Cilazapril—ABCB1—bone marrow—lung cancer	0.000397	0.00992	CbGeAlD
Cilazapril—ABCB1—lung—lung cancer	0.00036	0.00899	CbGeAlD
Cilazapril—ABCB1—lymph node—lung cancer	0.000246	0.00615	CbGeAlD
Cilazapril—Perindopril—ABCB1—lung cancer	0.000165	0.334	CrCbGaD
Cilazapril—Lisinopril—ABCB1—lung cancer	0.000146	0.295	CrCbGaD
Cilazapril—Somnolence—Etoposide—lung cancer	0.000124	0.00048	CcSEcCtD
Cilazapril—Cough—Docetaxel—lung cancer	0.000124	0.00048	CcSEcCtD
Cilazapril—Angina pectoris—Doxorubicin—lung cancer	0.000124	0.00048	CcSEcCtD
Cilazapril—Hepatobiliary disease—Methotrexate—lung cancer	0.000124	0.00048	CcSEcCtD
Cilazapril—Insomnia—Paclitaxel—lung cancer	0.000123	0.000479	CcSEcCtD
Cilazapril—Epistaxis—Methotrexate—lung cancer	0.000123	0.000479	CcSEcCtD
Cilazapril—Hypersensitivity—Irinotecan—lung cancer	0.000123	0.000478	CcSEcCtD
Cilazapril—Paraesthesia—Paclitaxel—lung cancer	0.000123	0.000476	CcSEcCtD
Cilazapril—Hypertension—Docetaxel—lung cancer	0.000122	0.000475	CcSEcCtD
Cilazapril—Bronchitis—Doxorubicin—lung cancer	0.000122	0.000474	CcSEcCtD
Cilazapril—Agranulocytosis—Methotrexate—lung cancer	0.000122	0.000473	CcSEcCtD
Cilazapril—Dyspnoea—Paclitaxel—lung cancer	0.000122	0.000472	CcSEcCtD
Cilazapril—Somnolence—Paclitaxel—lung cancer	0.000121	0.000471	CcSEcCtD
Cilazapril—Decreased appetite—Etoposide—lung cancer	0.000121	0.00047	CcSEcCtD
Cilazapril—Myalgia—Docetaxel—lung cancer	0.000121	0.000468	CcSEcCtD
Cilazapril—Chest pain—Docetaxel—lung cancer	0.000121	0.000468	CcSEcCtD
Cilazapril—Arthralgia—Docetaxel—lung cancer	0.000121	0.000468	CcSEcCtD
Cilazapril—Nausea—Vinorelbine—lung cancer	0.000121	0.000468	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Etoposide—lung cancer	0.00012	0.000466	CcSEcCtD
Cilazapril—Dyspepsia—Paclitaxel—lung cancer	0.00012	0.000466	CcSEcCtD
Cilazapril—Asthenia—Irinotecan—lung cancer	0.00012	0.000466	CcSEcCtD
Cilazapril—Fatigue—Etoposide—lung cancer	0.00012	0.000466	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.00012	0.000465	CcSEcCtD
Cilazapril—Pain—Etoposide—lung cancer	0.000119	0.000462	CcSEcCtD
Cilazapril—Constipation—Etoposide—lung cancer	0.000119	0.000462	CcSEcCtD
Cilazapril—Dysuria—Doxorubicin—lung cancer	0.000119	0.000461	CcSEcCtD
Cilazapril—Neutropenia—Doxorubicin—lung cancer	0.000119	0.000461	CcSEcCtD
Cilazapril—Decreased appetite—Paclitaxel—lung cancer	0.000119	0.00046	CcSEcCtD
Cilazapril—Dry mouth—Docetaxel—lung cancer	0.000118	0.000458	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000118	0.000457	CcSEcCtD
Cilazapril—Fatigue—Paclitaxel—lung cancer	0.000118	0.000457	CcSEcCtD
Cilazapril—Pollakiuria—Doxorubicin—lung cancer	0.000117	0.000455	CcSEcCtD
Cilazapril—Asthenia—Gemcitabine—lung cancer	0.000117	0.000454	CcSEcCtD
Cilazapril—ACE—Peptide hormone metabolism—KIF5B—lung cancer	0.000117	0.0565	CbGpPWpGaD
Cilazapril—Pain—Paclitaxel—lung cancer	0.000117	0.000453	CcSEcCtD
Cilazapril—Constipation—Paclitaxel—lung cancer	0.000117	0.000453	CcSEcCtD
Cilazapril—Confusional state—Docetaxel—lung cancer	0.000117	0.000453	CcSEcCtD
Cilazapril—Pharyngitis—Methotrexate—lung cancer	0.000117	0.000452	CcSEcCtD
Cilazapril—Urinary tract disorder—Methotrexate—lung cancer	0.000116	0.00045	CcSEcCtD
Cilazapril—Photosensitivity reaction—Doxorubicin—lung cancer	0.000116	0.00045	CcSEcCtD
Cilazapril—Oedema—Docetaxel—lung cancer	0.000116	0.000449	CcSEcCtD
Cilazapril—Pruritus—Gemcitabine—lung cancer	0.000115	0.000448	CcSEcCtD
Cilazapril—Urethral disorder—Methotrexate—lung cancer	0.000115	0.000446	CcSEcCtD
Cilazapril—Feeling abnormal—Etoposide—lung cancer	0.000115	0.000445	CcSEcCtD
Cilazapril—Hyperglycaemia—Doxorubicin—lung cancer	0.000115	0.000444	CcSEcCtD
Cilazapril—Diarrhoea—Irinotecan—lung cancer	0.000115	0.000444	CcSEcCtD
Cilazapril—Gastrointestinal pain—Etoposide—lung cancer	0.000114	0.000442	CcSEcCtD
Cilazapril—Shock—Docetaxel—lung cancer	0.000114	0.000442	CcSEcCtD
Cilazapril—Thrombocytopenia—Docetaxel—lung cancer	0.000113	0.00044	CcSEcCtD
Cilazapril—Visual impairment—Methotrexate—lung cancer	0.000113	0.000439	CcSEcCtD
Cilazapril—Tachycardia—Docetaxel—lung cancer	0.000113	0.000438	CcSEcCtD
Cilazapril—Feeling abnormal—Paclitaxel—lung cancer	0.000113	0.000436	CcSEcCtD
Cilazapril—Skin disorder—Docetaxel—lung cancer	0.000112	0.000436	CcSEcCtD
Cilazapril—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.000112	0.000436	CcSEcCtD
Cilazapril—Hypersensitivity—Cisplatin—lung cancer	0.000112	0.000434	CcSEcCtD
Cilazapril—ABCB1—Abacavir transmembrane transport—ABCG2—lung cancer	0.000112	0.0542	CbGpPWpGaD
Cilazapril—Gastrointestinal pain—Paclitaxel—lung cancer	0.000112	0.000433	CcSEcCtD
Cilazapril—Diarrhoea—Gemcitabine—lung cancer	0.000112	0.000433	CcSEcCtD
Cilazapril—Renal failure—Doxorubicin—lung cancer	0.000111	0.000432	CcSEcCtD
Cilazapril—Erythema multiforme—Methotrexate—lung cancer	0.000111	0.000431	CcSEcCtD
Cilazapril—Dizziness—Irinotecan—lung cancer	0.000111	0.000429	CcSEcCtD
Cilazapril—Urticaria—Etoposide—lung cancer	0.000111	0.000429	CcSEcCtD
Cilazapril—Anorexia—Docetaxel—lung cancer	0.00011	0.000428	CcSEcCtD
Cilazapril—Abdominal pain—Etoposide—lung cancer	0.00011	0.000427	CcSEcCtD
Cilazapril—Conjunctivitis—Doxorubicin—lung cancer	0.00011	0.000427	CcSEcCtD
Cilazapril—Tinnitus—Methotrexate—lung cancer	0.000109	0.000425	CcSEcCtD
Cilazapril—Asthenia—Cisplatin—lung cancer	0.000109	0.000423	CcSEcCtD
Cilazapril—Cardiac disorder—Methotrexate—lung cancer	0.000109	0.000423	CcSEcCtD
Cilazapril—Urticaria—Paclitaxel—lung cancer	0.000108	0.000421	CcSEcCtD
Cilazapril—Hypotension—Docetaxel—lung cancer	0.000108	0.00042	CcSEcCtD
Cilazapril—Abdominal pain—Paclitaxel—lung cancer	0.000108	0.000419	CcSEcCtD
Cilazapril—Hepatobiliary disease—Doxorubicin—lung cancer	0.000107	0.000415	CcSEcCtD
Cilazapril—Enalapril—ABCB1—lung cancer	0.000107	0.216	CrCbGaD
Cilazapril—Epistaxis—Doxorubicin—lung cancer	0.000107	0.000414	CcSEcCtD
Cilazapril—Angiopathy—Methotrexate—lung cancer	0.000107	0.000413	CcSEcCtD
Cilazapril—Vomiting—Irinotecan—lung cancer	0.000106	0.000413	CcSEcCtD
Cilazapril—Sinusitis—Doxorubicin—lung cancer	0.000106	0.000412	CcSEcCtD
Cilazapril—Immune system disorder—Methotrexate—lung cancer	0.000106	0.000411	CcSEcCtD
Cilazapril—Agranulocytosis—Doxorubicin—lung cancer	0.000106	0.00041	CcSEcCtD
Cilazapril—Rash—Irinotecan—lung cancer	0.000106	0.000409	CcSEcCtD
Cilazapril—Dermatitis—Irinotecan—lung cancer	0.000105	0.000409	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000105	0.000409	CcSEcCtD
Cilazapril—Chills—Methotrexate—lung cancer	0.000105	0.000409	CcSEcCtD
Cilazapril—Headache—Irinotecan—lung cancer	0.000105	0.000407	CcSEcCtD
Cilazapril—Insomnia—Docetaxel—lung cancer	0.000105	0.000406	CcSEcCtD
Cilazapril—Diarrhoea—Cisplatin—lung cancer	0.000104	0.000403	CcSEcCtD
Cilazapril—Paraesthesia—Docetaxel—lung cancer	0.000104	0.000403	CcSEcCtD
Cilazapril—Alopecia—Methotrexate—lung cancer	0.000104	0.000402	CcSEcCtD
Cilazapril—Vomiting—Gemcitabine—lung cancer	0.000104	0.000402	CcSEcCtD
Cilazapril—Bradycardia—Doxorubicin—lung cancer	0.000103	0.000401	CcSEcCtD
Cilazapril—Dyspnoea—Docetaxel—lung cancer	0.000103	0.0004	CcSEcCtD
Cilazapril—Somnolence—Docetaxel—lung cancer	0.000103	0.000399	CcSEcCtD
Cilazapril—Rash—Gemcitabine—lung cancer	0.000103	0.000399	CcSEcCtD
Cilazapril—Dermatitis—Gemcitabine—lung cancer	0.000103	0.000399	CcSEcCtD
Cilazapril—Hypersensitivity—Etoposide—lung cancer	0.000103	0.000398	CcSEcCtD
Cilazapril—Headache—Gemcitabine—lung cancer	0.000102	0.000396	CcSEcCtD
Cilazapril—Rhinitis—Doxorubicin—lung cancer	0.000102	0.000395	CcSEcCtD
Cilazapril—Dyspepsia—Docetaxel—lung cancer	0.000102	0.000395	CcSEcCtD
Cilazapril—Hypoaesthesia—Doxorubicin—lung cancer	0.000101	0.000392	CcSEcCtD
Cilazapril—Pharyngitis—Doxorubicin—lung cancer	0.000101	0.000391	CcSEcCtD
Cilazapril—Decreased appetite—Docetaxel—lung cancer	0.000101	0.00039	CcSEcCtD
Cilazapril—Hypersensitivity—Paclitaxel—lung cancer	0.000101	0.00039	CcSEcCtD
Cilazapril—Urinary tract disorder—Doxorubicin—lung cancer	0.0001	0.000389	CcSEcCtD
Cilazapril—Dysgeusia—Methotrexate—lung cancer	0.0001	0.000388	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Docetaxel—lung cancer	9.99e-05	0.000388	CcSEcCtD
Cilazapril—Asthenia—Etoposide—lung cancer	9.99e-05	0.000388	CcSEcCtD
Cilazapril—Fatigue—Docetaxel—lung cancer	9.98e-05	0.000387	CcSEcCtD
Cilazapril—Urethral disorder—Doxorubicin—lung cancer	9.96e-05	0.000387	CcSEcCtD
Cilazapril—Nausea—Irinotecan—lung cancer	9.94e-05	0.000386	CcSEcCtD
Cilazapril—Constipation—Docetaxel—lung cancer	9.9e-05	0.000384	CcSEcCtD
Cilazapril—Pain—Docetaxel—lung cancer	9.9e-05	0.000384	CcSEcCtD
Cilazapril—Pruritus—Etoposide—lung cancer	9.85e-05	0.000382	CcSEcCtD
Cilazapril—Visual impairment—Doxorubicin—lung cancer	9.8e-05	0.00038	CcSEcCtD
Cilazapril—Asthenia—Paclitaxel—lung cancer	9.8e-05	0.00038	CcSEcCtD
Cilazapril—Nausea—Gemcitabine—lung cancer	9.69e-05	0.000376	CcSEcCtD
Cilazapril—Vomiting—Cisplatin—lung cancer	9.66e-05	0.000375	CcSEcCtD
Cilazapril—Pruritus—Paclitaxel—lung cancer	9.66e-05	0.000375	CcSEcCtD
Cilazapril—Erythema multiforme—Doxorubicin—lung cancer	9.61e-05	0.000373	CcSEcCtD
Cilazapril—Rash—Cisplatin—lung cancer	9.58e-05	0.000372	CcSEcCtD
Cilazapril—Dermatitis—Cisplatin—lung cancer	9.57e-05	0.000371	CcSEcCtD
Cilazapril—Feeling abnormal—Docetaxel—lung cancer	9.54e-05	0.00037	CcSEcCtD
Cilazapril—Diarrhoea—Etoposide—lung cancer	9.53e-05	0.00037	CcSEcCtD
Cilazapril—Ill-defined disorder—Methotrexate—lung cancer	9.48e-05	0.000368	CcSEcCtD
Cilazapril—Tinnitus—Doxorubicin—lung cancer	9.48e-05	0.000368	CcSEcCtD
Cilazapril—Gastrointestinal pain—Docetaxel—lung cancer	9.46e-05	0.000367	CcSEcCtD
Cilazapril—Anaemia—Methotrexate—lung cancer	9.45e-05	0.000366	CcSEcCtD
Cilazapril—Cardiac disorder—Doxorubicin—lung cancer	9.43e-05	0.000366	CcSEcCtD
Cilazapril—Flushing—Doxorubicin—lung cancer	9.43e-05	0.000366	CcSEcCtD
Cilazapril—ABCB1—Codeine and Morphine Metabolism—ABCC3—lung cancer	9.42e-05	0.0456	CbGpPWpGaD
Cilazapril—Diarrhoea—Paclitaxel—lung cancer	9.34e-05	0.000362	CcSEcCtD
Cilazapril—Angiopathy—Doxorubicin—lung cancer	9.22e-05	0.000358	CcSEcCtD
Cilazapril—Malaise—Methotrexate—lung cancer	9.22e-05	0.000358	CcSEcCtD
Cilazapril—Dizziness—Etoposide—lung cancer	9.21e-05	0.000357	CcSEcCtD
Cilazapril—Immune system disorder—Doxorubicin—lung cancer	9.18e-05	0.000356	CcSEcCtD
Cilazapril—Vertigo—Methotrexate—lung cancer	9.18e-05	0.000356	CcSEcCtD
Cilazapril—Abdominal pain—Docetaxel—lung cancer	9.15e-05	0.000355	CcSEcCtD
Cilazapril—Leukopenia—Methotrexate—lung cancer	9.15e-05	0.000355	CcSEcCtD
Cilazapril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC34A2—lung cancer	9.14e-05	0.0442	CbGpPWpGaD
Cilazapril—Chills—Doxorubicin—lung cancer	9.12e-05	0.000354	CcSEcCtD
Cilazapril—Arrhythmia—Doxorubicin—lung cancer	9.08e-05	0.000352	CcSEcCtD
Cilazapril—Dizziness—Paclitaxel—lung cancer	9.03e-05	0.00035	CcSEcCtD
Cilazapril—Nausea—Cisplatin—lung cancer	9.03e-05	0.00035	CcSEcCtD
Cilazapril—Alopecia—Doxorubicin—lung cancer	8.98e-05	0.000348	CcSEcCtD
Cilazapril—Cough—Methotrexate—lung cancer	8.92e-05	0.000346	CcSEcCtD
Cilazapril—ABCB1—Codeine and Morphine Metabolism—UGT1A1—lung cancer	8.86e-05	0.0429	CbGpPWpGaD
Cilazapril—Vomiting—Etoposide—lung cancer	8.85e-05	0.000343	CcSEcCtD
Cilazapril—Rash—Etoposide—lung cancer	8.78e-05	0.000341	CcSEcCtD
Cilazapril—Dermatitis—Etoposide—lung cancer	8.77e-05	0.00034	CcSEcCtD
Cilazapril—Headache—Etoposide—lung cancer	8.72e-05	0.000338	CcSEcCtD
Cilazapril—Flatulence—Doxorubicin—lung cancer	8.72e-05	0.000338	CcSEcCtD
Cilazapril—Arthralgia—Methotrexate—lung cancer	8.7e-05	0.000338	CcSEcCtD
Cilazapril—Chest pain—Methotrexate—lung cancer	8.7e-05	0.000338	CcSEcCtD
Cilazapril—Myalgia—Methotrexate—lung cancer	8.7e-05	0.000338	CcSEcCtD
Cilazapril—Tension—Doxorubicin—lung cancer	8.68e-05	0.000337	CcSEcCtD
Cilazapril—Vomiting—Paclitaxel—lung cancer	8.68e-05	0.000337	CcSEcCtD
Cilazapril—Dysgeusia—Doxorubicin—lung cancer	8.67e-05	0.000336	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	8.64e-05	0.000335	CcSEcCtD
Cilazapril—Rash—Paclitaxel—lung cancer	8.61e-05	0.000334	CcSEcCtD
Cilazapril—Dermatitis—Paclitaxel—lung cancer	8.6e-05	0.000334	CcSEcCtD
Cilazapril—Discomfort—Methotrexate—lung cancer	8.6e-05	0.000334	CcSEcCtD
Cilazapril—Nervousness—Doxorubicin—lung cancer	8.59e-05	0.000333	CcSEcCtD
Cilazapril—Headache—Paclitaxel—lung cancer	8.55e-05	0.000332	CcSEcCtD
Cilazapril—Hypersensitivity—Docetaxel—lung cancer	8.53e-05	0.000331	CcSEcCtD
Cilazapril—Muscle spasms—Doxorubicin—lung cancer	8.51e-05	0.00033	CcSEcCtD
Cilazapril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC34A2—lung cancer	8.48e-05	0.041	CbGpPWpGaD
Cilazapril—Confusional state—Methotrexate—lung cancer	8.41e-05	0.000326	CcSEcCtD
Cilazapril—Asthenia—Docetaxel—lung cancer	8.3e-05	0.000322	CcSEcCtD
Cilazapril—Nausea—Etoposide—lung cancer	8.27e-05	0.000321	CcSEcCtD
Cilazapril—Ill-defined disorder—Doxorubicin—lung cancer	8.21e-05	0.000319	CcSEcCtD
Cilazapril—Pruritus—Docetaxel—lung cancer	8.19e-05	0.000318	CcSEcCtD
Cilazapril—Anaemia—Doxorubicin—lung cancer	8.18e-05	0.000317	CcSEcCtD
Cilazapril—Thrombocytopenia—Methotrexate—lung cancer	8.17e-05	0.000317	CcSEcCtD
Cilazapril—Nausea—Paclitaxel—lung cancer	8.11e-05	0.000315	CcSEcCtD
Cilazapril—Skin disorder—Methotrexate—lung cancer	8.1e-05	0.000314	CcSEcCtD
Cilazapril—Hyperhidrosis—Methotrexate—lung cancer	8.06e-05	0.000313	CcSEcCtD
Cilazapril—Malaise—Doxorubicin—lung cancer	7.98e-05	0.00031	CcSEcCtD
Cilazapril—Vertigo—Doxorubicin—lung cancer	7.95e-05	0.000308	CcSEcCtD
Cilazapril—Anorexia—Methotrexate—lung cancer	7.95e-05	0.000308	CcSEcCtD
Cilazapril—Syncope—Doxorubicin—lung cancer	7.94e-05	0.000308	CcSEcCtD
Cilazapril—Leukopenia—Doxorubicin—lung cancer	7.92e-05	0.000307	CcSEcCtD
Cilazapril—Diarrhoea—Docetaxel—lung cancer	7.92e-05	0.000307	CcSEcCtD
Cilazapril—Palpitations—Doxorubicin—lung cancer	7.82e-05	0.000303	CcSEcCtD
Cilazapril—Hypotension—Methotrexate—lung cancer	7.79e-05	0.000302	CcSEcCtD
Cilazapril—Loss of consciousness—Doxorubicin—lung cancer	7.78e-05	0.000302	CcSEcCtD
Cilazapril—Cough—Doxorubicin—lung cancer	7.72e-05	0.0003	CcSEcCtD
Cilazapril—Dizziness—Docetaxel—lung cancer	7.65e-05	0.000297	CcSEcCtD
Cilazapril—Nateglinide—ALB—lung cancer	7.64e-05	0.155	CrCbGaD
Cilazapril—Hypertension—Doxorubicin—lung cancer	7.64e-05	0.000296	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Methotrexate—lung cancer	7.6e-05	0.000295	CcSEcCtD
Cilazapril—Insomnia—Methotrexate—lung cancer	7.54e-05	0.000293	CcSEcCtD
Cilazapril—Arthralgia—Doxorubicin—lung cancer	7.53e-05	0.000292	CcSEcCtD
Cilazapril—Myalgia—Doxorubicin—lung cancer	7.53e-05	0.000292	CcSEcCtD
Cilazapril—Chest pain—Doxorubicin—lung cancer	7.53e-05	0.000292	CcSEcCtD
Cilazapril—Anxiety—Doxorubicin—lung cancer	7.51e-05	0.000291	CcSEcCtD
Cilazapril—Paraesthesia—Methotrexate—lung cancer	7.49e-05	0.000291	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	7.48e-05	0.00029	CcSEcCtD
Cilazapril—Discomfort—Doxorubicin—lung cancer	7.44e-05	0.000289	CcSEcCtD
Cilazapril—Dyspnoea—Methotrexate—lung cancer	7.44e-05	0.000288	CcSEcCtD
Cilazapril—Somnolence—Methotrexate—lung cancer	7.41e-05	0.000288	CcSEcCtD
Cilazapril—Dry mouth—Doxorubicin—lung cancer	7.37e-05	0.000286	CcSEcCtD
Cilazapril—Vomiting—Docetaxel—lung cancer	7.36e-05	0.000285	CcSEcCtD
Cilazapril—Dyspepsia—Methotrexate—lung cancer	7.34e-05	0.000285	CcSEcCtD
Cilazapril—Rash—Docetaxel—lung cancer	7.3e-05	0.000283	CcSEcCtD
Cilazapril—Dermatitis—Docetaxel—lung cancer	7.29e-05	0.000283	CcSEcCtD
Cilazapril—Confusional state—Doxorubicin—lung cancer	7.28e-05	0.000283	CcSEcCtD
Cilazapril—Decreased appetite—Methotrexate—lung cancer	7.25e-05	0.000281	CcSEcCtD
Cilazapril—Headache—Docetaxel—lung cancer	7.25e-05	0.000281	CcSEcCtD
Cilazapril—Oedema—Doxorubicin—lung cancer	7.22e-05	0.00028	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Methotrexate—lung cancer	7.2e-05	0.000279	CcSEcCtD
Cilazapril—Fatigue—Methotrexate—lung cancer	7.19e-05	0.000279	CcSEcCtD
Cilazapril—Pain—Methotrexate—lung cancer	7.13e-05	0.000277	CcSEcCtD
Cilazapril—Shock—Doxorubicin—lung cancer	7.11e-05	0.000276	CcSEcCtD
Cilazapril—Thrombocytopenia—Doxorubicin—lung cancer	7.07e-05	0.000274	CcSEcCtD
Cilazapril—Tachycardia—Doxorubicin—lung cancer	7.05e-05	0.000273	CcSEcCtD
Cilazapril—ACE—Peptide hormone metabolism—GRP—lung cancer	7.04e-05	0.0341	CbGpPWpGaD
Cilazapril—Skin disorder—Doxorubicin—lung cancer	7.01e-05	0.000272	CcSEcCtD
Cilazapril—Hyperhidrosis—Doxorubicin—lung cancer	6.98e-05	0.000271	CcSEcCtD
Cilazapril—Anorexia—Doxorubicin—lung cancer	6.88e-05	0.000267	CcSEcCtD
Cilazapril—Nausea—Docetaxel—lung cancer	6.87e-05	0.000267	CcSEcCtD
Cilazapril—Feeling abnormal—Methotrexate—lung cancer	6.87e-05	0.000267	CcSEcCtD
Cilazapril—Gastrointestinal pain—Methotrexate—lung cancer	6.82e-05	0.000265	CcSEcCtD
Cilazapril—Hypotension—Doxorubicin—lung cancer	6.75e-05	0.000262	CcSEcCtD
Cilazapril—Urticaria—Methotrexate—lung cancer	6.63e-05	0.000257	CcSEcCtD
Cilazapril—Abdominal pain—Methotrexate—lung cancer	6.59e-05	0.000256	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Doxorubicin—lung cancer	6.58e-05	0.000255	CcSEcCtD
Cilazapril—Insomnia—Doxorubicin—lung cancer	6.53e-05	0.000253	CcSEcCtD
Cilazapril—Paraesthesia—Doxorubicin—lung cancer	6.48e-05	0.000252	CcSEcCtD
Cilazapril—Dyspnoea—Doxorubicin—lung cancer	6.44e-05	0.00025	CcSEcCtD
Cilazapril—ABCB1—Abacavir transport and metabolism—ABCG2—lung cancer	6.43e-05	0.0311	CbGpPWpGaD
Cilazapril—Somnolence—Doxorubicin—lung cancer	6.42e-05	0.000249	CcSEcCtD
Cilazapril—Dyspepsia—Doxorubicin—lung cancer	6.36e-05	0.000247	CcSEcCtD
Cilazapril—Decreased appetite—Doxorubicin—lung cancer	6.28e-05	0.000244	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Doxorubicin—lung cancer	6.23e-05	0.000242	CcSEcCtD
Cilazapril—Fatigue—Doxorubicin—lung cancer	6.23e-05	0.000242	CcSEcCtD
Cilazapril—Pain—Doxorubicin—lung cancer	6.18e-05	0.00024	CcSEcCtD
Cilazapril—Constipation—Doxorubicin—lung cancer	6.18e-05	0.00024	CcSEcCtD
Cilazapril—Hypersensitivity—Methotrexate—lung cancer	6.14e-05	0.000238	CcSEcCtD
Cilazapril—Asthenia—Methotrexate—lung cancer	5.98e-05	0.000232	CcSEcCtD
Cilazapril—Feeling abnormal—Doxorubicin—lung cancer	5.95e-05	0.000231	CcSEcCtD
Cilazapril—Gastrointestinal pain—Doxorubicin—lung cancer	5.91e-05	0.000229	CcSEcCtD
Cilazapril—Pruritus—Methotrexate—lung cancer	5.9e-05	0.000229	CcSEcCtD
Cilazapril—Urticaria—Doxorubicin—lung cancer	5.74e-05	0.000223	CcSEcCtD
Cilazapril—Abdominal pain—Doxorubicin—lung cancer	5.71e-05	0.000221	CcSEcCtD
Cilazapril—Diarrhoea—Methotrexate—lung cancer	5.71e-05	0.000221	CcSEcCtD
Cilazapril—Dizziness—Methotrexate—lung cancer	5.52e-05	0.000214	CcSEcCtD
Cilazapril—Hypersensitivity—Doxorubicin—lung cancer	5.32e-05	0.000206	CcSEcCtD
Cilazapril—Vomiting—Methotrexate—lung cancer	5.3e-05	0.000206	CcSEcCtD
Cilazapril—Rash—Methotrexate—lung cancer	5.26e-05	0.000204	CcSEcCtD
Cilazapril—Dermatitis—Methotrexate—lung cancer	5.25e-05	0.000204	CcSEcCtD
Cilazapril—Headache—Methotrexate—lung cancer	5.22e-05	0.000203	CcSEcCtD
Cilazapril—Asthenia—Doxorubicin—lung cancer	5.18e-05	0.000201	CcSEcCtD
Cilazapril—ABCB1—Drug Induction of Bile Acid Pathway—ABCC3—lung cancer	5.16e-05	0.025	CbGpPWpGaD
Cilazapril—Pruritus—Doxorubicin—lung cancer	5.11e-05	0.000198	CcSEcCtD
Cilazapril—Nausea—Methotrexate—lung cancer	4.95e-05	0.000192	CcSEcCtD
Cilazapril—Diarrhoea—Doxorubicin—lung cancer	4.94e-05	0.000192	CcSEcCtD
Cilazapril—Dizziness—Doxorubicin—lung cancer	4.78e-05	0.000185	CcSEcCtD
Cilazapril—Vomiting—Doxorubicin—lung cancer	4.59e-05	0.000178	CcSEcCtD
Cilazapril—Rash—Doxorubicin—lung cancer	4.55e-05	0.000177	CcSEcCtD
Cilazapril—Dermatitis—Doxorubicin—lung cancer	4.55e-05	0.000177	CcSEcCtD
Cilazapril—Headache—Doxorubicin—lung cancer	4.52e-05	0.000176	CcSEcCtD
Cilazapril—Nausea—Doxorubicin—lung cancer	4.29e-05	0.000166	CcSEcCtD
Cilazapril—SLC15A2—SLC-mediated transmembrane transport—SLC34A2—lung cancer	4.08e-05	0.0198	CbGpPWpGaD
Cilazapril—SLC15A1—SLC-mediated transmembrane transport—SLC34A2—lung cancer	3.79e-05	0.0183	CbGpPWpGaD
Cilazapril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—HMGB2—lung cancer	3.43e-05	0.0166	CbGpPWpGaD
Cilazapril—ABCB1—Constitutive Androstane Receptor Pathway—GSTA2—lung cancer	3.26e-05	0.0158	CbGpPWpGaD
Cilazapril—ABCB1—Constitutive Androstane Receptor Pathway—ABCC3—lung cancer	3.11e-05	0.015	CbGpPWpGaD
Cilazapril—SLC15A2—SLC-mediated transmembrane transport—SLC22A18—lung cancer	3.09e-05	0.015	CbGpPWpGaD
Cilazapril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC3—lung cancer	2.96e-05	0.0143	CbGpPWpGaD
Cilazapril—ABCB1—Constitutive Androstane Receptor Pathway—UGT1A1—lung cancer	2.92e-05	0.0141	CbGpPWpGaD
Cilazapril—SLC15A1—SLC-mediated transmembrane transport—SLC22A18—lung cancer	2.87e-05	0.0139	CbGpPWpGaD
Cilazapril—ABCB1—ABC-family proteins mediated transport—ABCC3—lung cancer	2.83e-05	0.0137	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—EIF2B4—lung cancer	2.81e-05	0.0136	CbGpPWpGaD
Cilazapril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—lung cancer	2.71e-05	0.0131	CbGpPWpGaD
Cilazapril—ACE—Peptide hormone metabolism—POMC—lung cancer	2.54e-05	0.0123	CbGpPWpGaD
Cilazapril—ABCB1—Constitutive Androstane Receptor Pathway—CYP2A6—lung cancer	2.38e-05	0.0115	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—KHSRP—lung cancer	2.29e-05	0.0111	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—KIF5B—lung cancer	2.2e-05	0.0107	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—SLC34A2—lung cancer	2.08e-05	0.01	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—NDRG1—lung cancer	2.05e-05	0.00992	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—MCL1—lung cancer	2.05e-05	0.00992	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—EIF2B5—lung cancer	2e-05	0.00969	CbGpPWpGaD
Cilazapril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—lung cancer	1.93e-05	0.00934	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—SLC34A2—lung cancer	1.93e-05	0.00932	CbGpPWpGaD
Cilazapril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—lung cancer	1.8e-05	0.00872	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—ST3GAL5—lung cancer	1.7e-05	0.00824	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—SLC22A18—lung cancer	1.57e-05	0.00761	CbGpPWpGaD
Cilazapril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—lung cancer	1.53e-05	0.00738	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—B4GALT5—lung cancer	1.52e-05	0.00734	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—ADAMTS1—lung cancer	1.52e-05	0.00734	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—ALDOA—lung cancer	1.5e-05	0.00728	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—SLC22A18—lung cancer	1.46e-05	0.00706	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—ABCG2—lung cancer	1.42e-05	0.00687	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—GRP—lung cancer	1.33e-05	0.00643	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—TF—lung cancer	1.32e-05	0.00639	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—ENO1—lung cancer	1.27e-05	0.00613	CbGpPWpGaD
Cilazapril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FOXO3—lung cancer	1.24e-05	0.006	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—ATF3—lung cancer	1.16e-05	0.0056	CbGpPWpGaD
Cilazapril—ABCB1—ABC-family proteins mediated transport—APOA1—lung cancer	1.14e-05	0.0055	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—TOP1—lung cancer	1.06e-05	0.00511	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—LMNA—lung cancer	1.04e-05	0.00503	CbGpPWpGaD
Cilazapril—SLC15A2—SLC-mediated transmembrane transport—AVP—lung cancer	9.74e-06	0.00471	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—ABCC3—lung cancer	9.42e-06	0.00456	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—RHEB—lung cancer	9.24e-06	0.00447	CbGpPWpGaD
Cilazapril—SLC15A1—SLC-mediated transmembrane transport—AVP—lung cancer	9.04e-06	0.00438	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—lung cancer	8.76e-06	0.00424	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—NODAL—lung cancer	8.76e-06	0.00424	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—ABCC3—lung cancer	8.74e-06	0.00423	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—GNG11—lung cancer	8.54e-06	0.00413	CbGpPWpGaD
Cilazapril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—lung cancer	8.11e-06	0.00392	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—GNG11—lung cancer	7.93e-06	0.00384	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—ADCY1—lung cancer	7.68e-06	0.00372	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—ABCG2—lung cancer	7.68e-06	0.00372	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—TERT—lung cancer	7.58e-06	0.00367	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—IL10—lung cancer	7.45e-06	0.00361	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—HIF1A—lung cancer	7.25e-06	0.00351	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—TF—lung cancer	7.14e-06	0.00346	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—ABCG2—lung cancer	7.13e-06	0.00345	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—ADCY1—lung cancer	7.13e-06	0.00345	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—FASLG—lung cancer	6.93e-06	0.00335	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—lung cancer	6.81e-06	0.0033	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—TF—lung cancer	6.63e-06	0.00321	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLC34A2—lung cancer	6.51e-06	0.00315	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—lung cancer	5.95e-06	0.00288	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—CREBBP—lung cancer	5.92e-06	0.00287	CbGpPWpGaD
Cilazapril—SLC15A2—SLC-mediated transmembrane transport—ALB—lung cancer	5.9e-06	0.00286	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—MMP1—lung cancer	5.76e-06	0.00279	CbGpPWpGaD
Cilazapril—SLC15A1—SLC-mediated transmembrane transport—ALB—lung cancer	5.48e-06	0.00265	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—lung cancer	5.31e-06	0.00257	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—CASP8—lung cancer	5.15e-06	0.00249	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—APP—lung cancer	5.03e-06	0.00243	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—AVP—lung cancer	4.95e-06	0.0024	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLC22A18—lung cancer	4.93e-06	0.00239	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—ABCB1—lung cancer	4.79e-06	0.00232	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—POMC—lung cancer	4.79e-06	0.00232	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—lung cancer	4.76e-06	0.00231	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—AVP—lung cancer	4.59e-06	0.00222	CbGpPWpGaD
Cilazapril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—lung cancer	4.46e-06	0.00216	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—MMP2—lung cancer	4.46e-06	0.00216	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—ABCB1—lung cancer	4.45e-06	0.00215	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—JUN—lung cancer	4.37e-06	0.00212	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—lung cancer	4.32e-06	0.00209	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—CXCL8—lung cancer	4.07e-06	0.00197	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—EP300—lung cancer	4.03e-06	0.00195	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—CASP3—lung cancer	3.9e-06	0.00189	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—IL2—lung cancer	3.89e-06	0.00188	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—VEGFA—lung cancer	3.82e-06	0.00185	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—APOA1—lung cancer	3.78e-06	0.00183	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—lung cancer	3.72e-06	0.0018	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—CXCL8—lung cancer	3.7e-06	0.00179	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—APOA1—lung cancer	3.51e-06	0.0017	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—lung cancer	3.42e-06	0.00165	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—COL4A3BP—lung cancer	3.33e-06	0.00161	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—AZIN2—lung cancer	3.33e-06	0.00161	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—VEGFA—lung cancer	3.31e-06	0.0016	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—CREBBP—lung cancer	3.2e-06	0.00155	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—lung cancer	3.15e-06	0.00152	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—ALB—lung cancer	3e-06	0.00145	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—CREBBP—lung cancer	2.97e-06	0.00144	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—ABCC3—lung cancer	2.96e-06	0.00143	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ATP5H—lung cancer	2.84e-06	0.00137	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—ALB—lung cancer	2.78e-06	0.00135	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—APC—lung cancer	2.73e-06	0.00132	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—RAF1—lung cancer	2.71e-06	0.00131	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—lung cancer	2.7e-06	0.00131	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—GNG11—lung cancer	2.68e-06	0.0013	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—lung cancer	2.54e-06	0.00123	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—lung cancer	2.53e-06	0.00123	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PLBD1—lung cancer	2.53e-06	0.00122	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—RAF1—lung cancer	2.52e-06	0.00122	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—AKT1—lung cancer	2.44e-06	0.00118	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—lung cancer	2.42e-06	0.00117	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—ADCY1—lung cancer	2.41e-06	0.00117	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—ABCG2—lung cancer	2.41e-06	0.00117	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—HSD17B10—lung cancer	2.31e-06	0.00112	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—TF—lung cancer	2.24e-06	0.00108	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—lung cancer	2.15e-06	0.00104	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CKB—lung cancer	2.15e-06	0.00104	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	2.14e-06	0.00104	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	2.12e-06	0.00103	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—lung cancer	2.07e-06	0.001	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GSTM2—lung cancer	2.02e-06	0.000978	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CNDP2—lung cancer	2.02e-06	0.000978	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—MTMR3—lung cancer	1.97e-06	0.000951	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	1.92e-06	0.000931	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PGAM1—lung cancer	1.92e-06	0.000927	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	1.87e-06	0.000907	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	1.87e-06	0.000905	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CYP2A7—lung cancer	1.83e-06	0.000884	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	1.81e-06	0.000877	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	1.81e-06	0.000875	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—SDC4—lung cancer	1.79e-06	0.000865	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	1.72e-06	0.000835	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	1.68e-06	0.000812	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	1.63e-06	0.00079	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—RRM1—lung cancer	1.63e-06	0.000788	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GSTA3—lung cancer	1.63e-06	0.000788	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—AVP—lung cancer	1.55e-06	0.000752	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	1.54e-06	0.000748	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—B4GALT5—lung cancer	1.53e-06	0.000741	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	1.5e-06	0.000727	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GSTA4—lung cancer	1.49e-06	0.000721	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	1.47e-06	0.000711	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GSTA2—lung cancer	1.45e-06	0.000703	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GSTA1—lung cancer	1.4e-06	0.000678	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	1.39e-06	0.000672	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ABCC3—lung cancer	1.38e-06	0.00067	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—AKR1C1—lung cancer	1.34e-06	0.000649	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—UGT1A1—lung cancer	1.3e-06	0.00063	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	1.28e-06	0.000617	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GNG11—lung cancer	1.26e-06	0.000608	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	1.23e-06	0.000597	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ALDOA—lung cancer	1.2e-06	0.000579	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—APOA1—lung cancer	1.19e-06	0.000575	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—NCOA3—lung cancer	1.16e-06	0.000562	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ABCG2—lung cancer	1.13e-06	0.000546	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ADCY1—lung cancer	1.13e-06	0.000546	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ENO2—lung cancer	1.11e-06	0.000536	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—HPGDS—lung cancer	1.11e-06	0.000536	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PPP2R1B—lung cancer	1.1e-06	0.000532	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GSTT1—lung cancer	1.07e-06	0.00052	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GCLC—lung cancer	1.06e-06	0.000514	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CYP2A6—lung cancer	1.06e-06	0.000514	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	1.04e-06	0.000504	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ENO1—lung cancer	1.01e-06	0.000487	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	1.01e-06	0.000487	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	9.41e-07	0.000455	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CYP2E1—lung cancer	9.02e-07	0.000437	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—NQO1—lung cancer	8.92e-07	0.000432	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	8.51e-07	0.000412	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—STK11—lung cancer	8.04e-07	0.000389	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GSTP1—lung cancer	7.44e-07	0.00036	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CAT—lung cancer	7.24e-07	0.00035	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—TYMS—lung cancer	6.92e-07	0.000335	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GSTM1—lung cancer	6.84e-07	0.000331	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CYP1A1—lung cancer	6.48e-07	0.000314	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ERCC2—lung cancer	6.43e-07	0.000311	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—APOA1—lung cancer	5.56e-07	0.000269	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PIK3CG—lung cancer	5.08e-07	0.000246	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—POMC—lung cancer	4.83e-07	0.000234	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CREBBP—lung cancer	4.71e-07	0.000228	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PIK3CD—lung cancer	4.46e-07	0.000216	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ALB—lung cancer	4.41e-07	0.000213	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PIK3CB—lung cancer	3.89e-07	0.000188	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PTGS2—lung cancer	3.86e-07	0.000187	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PTEN—lung cancer	3.36e-07	0.000163	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—EP300—lung cancer	3.21e-07	0.000155	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PIK3CA—lung cancer	2.37e-07	0.000115	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—AKT1—lung cancer	1.94e-07	9.38e-05	CbGpPWpGaD
